GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Oncozenge ONCOZ.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

3.30

+4.43%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Oncozenge — daily ONCOZ

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Oncozenge on TradingView ↗
Market value
SEK 41.7m
Last close × shares
Volume
265.1k
Shares, 9 Nov 2026

About Oncozenge

Its shares trade on Nasdaq Stockholm under the ticker ONCOZ.ST. It has been listed since 12 February 2021. In the fiscal year to 31 December 2025, it reported revenue of SEK 2.7m and a net loss of SEK 15.9m. At that date it held total assets of SEK 15.3m and shareholders' equity of −SEK 587,000.

OncoZenge AB operates as a pharmaceutical company. The company is headquartered in Bromma, Stockholm. The company went IPO on 2021-02-12. OncoZenge's vision is to improve the quality of life for patients with severe oral pain, for example caused by radiotherapy or chemotherapy in the treatment of cancer. The firm works on the introduction of its project BupiZenge. Its strategic and operational work focuses on the development of BupiZenge, which is a formulation of bupivacaine in the form of a lozenge. BupiZenge meets a need for pain relief in the mouth and throat, for example associated with oral mucositis, a serious complication after radiation or other cancer treatment. Preparations for registration establishment clinical studies are ongoing.

Figures and description from our data supplier, not checked against the company's own report.

More about Oncozenge →

Latest on Oncozenge

Our reporting

We have not reported on Oncozenge yet.

Next results

11 Nov 2026

Due on 11 Nov 2026.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Oncozenge's ticker?

Oncozenge trades as ONCOZ.ST on Nasdaq Stockholm, under ISIN SE0015504097.

What was Oncozenge's last closing price?

3.30 on 9 Nov 2026. The figure is in SEK and is never converted.

When does Oncozenge next report results?

Results are expected on 11 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.